The breakthrough in pulmonary drug delivery recently announced by
Next Safety is basic in nature and has broad implications for the
treatment of a number of medical conditions. In the area of nicotine
alone, the potential is enormous. The efficacy of Next Safety's
nicotine delivery method is far higher than cigarettes, and Next
Safety believes this makes it the only means currently capable of
replacing tobacco.
In November, Next Safety will offer bulk purchases of nicotine
delivery products to certain European countries that are exploring
programs to reduce the impact of tobacco products on national health
care costs.
